Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment: Results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)

OBJECTIVE: To evaluate the efficacy and safety of taspoglutide monotherapy in drug-naive patients with type 2 diabetes inadequately controlled. RESEARCH DESIGN AND METHODS: In this 24-week double-blind, placebo-controlled, multicenter trial, 373 patients with type 2 diabetes naive to antihyperglycem...

Descripción completa

Detalles Bibliográficos
Autores principales: Raz, Itamar, Fonseca, Vivian, Kipnes, Mark, Durrwell, Laurence, Hoekstra, John, Boldrin, Mark, Balena, Raffaella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322710/
https://www.ncbi.nlm.nih.gov/pubmed/22301126
http://dx.doi.org/10.2337/dc11-1942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322710/
https://www.ncbi.nlm.nih.gov/pubmed/22301126
http://dx.doi.org/10.2337/dc11-1942

Ejemplares similares